Publicacións (9) Publicacións de Antonio Perez Landeiro

2023

  1. Carbapenem alternatives for treatment of bloodstream infections due to AmpC producing enterobacterales

    Annals of Clinical Microbiology and Antimicrobials, Vol. 22, Núm. 1

2022

  1. Ceftazidime–avibactam treatment in bacteremia caused by OXA-48 carbapenemase-producing Klebsiella pneumoniae

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 41, Núm. 9, pp. 1173-1182

  2. Cerebrospinal fluid drainage-related ventriculitis due to multidrug-resistant microorganisms

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 40, Núm. 6, pp. 322-325

2021

  1. Mortality-related factors in patients with OXA-48 carbapenemase-producing Klebsiella pneumoniae bacteremia

    Medicine, Vol. 100, Núm. 14, pp. e24880

  2. Real-world prevalence and consequences of potential drug-drug interactions in the first-wave COVID-19 treatments

    Journal of Clinical Pharmacy and Therapeutics, Vol. 46, Núm. 3, pp. 724-730

2018

  1. Effectiveness of ceftazidime/avibactam as salvage therapy for treatment of infections due to OXA-48 carbapenemase-producing Enterobacteriaceae

    Journal of Antimicrobial Chemotherapy, Vol. 73, Núm. 11, pp. 3170-3175

2017

  1. Successful treatment of MDR Pseudomonas aeruginosa skin and soft-tissue infection with ceftolozane/tazobactam

    Journal of Antimicrobial Chemotherapy

2016

  1. Short stay unit and emergency department: Pharmacotherapeutic interventions and its impact

    American Journal of Therapeutics, Vol. 23, Núm. 6, pp. e1307-e1314

2008

  1. Our experience with the Isofar ® program

    Farmacia Hospitalaria